Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Nuclear Medicine

  Free Subscription


Articles published in Nuklearmedizin

Retrieve available abstracts of 62 articles:
HTML format



Single Articles


    June 2025
  1. LIU S, Pan Q, Xu H, Luo Y, et al
    Activation of fibroblast in intestinal Behcet's disease shown by 68Ga-FAPI-04 PET/CT.
    Nuklearmedizin. 2025;64:231-233.
    PubMed    


  2. YANG H, Zhang Y, Guan Z, Li C, et al
    The diagnostic performance of an [18F]FDG PET/CT algorithm for preoperative evaluation of extrahepatic cholangiocarcinoma: a retrospective study.
    Nuklearmedizin. 2025;64:205-214.
    PubMed     Abstract available


  3. DROPMANN JA, Kleespies A, Fuerst H, Kremer M, et al
    Importance of oxyphil cells for 99mTc-sestamibi uptake in primary hyperparathyroidism: a retrospective observational study.
    Nuklearmedizin. 2025;64:215-224.
    PubMed     Abstract available


    May 2025
  4. WENDLER T, Rogasch JMM, Bastian MB, Burchert W, et al
    Correction: Digitalization of Nuclear Medicine in Germany - Status Quo 2024.
    Nuklearmedizin. 2025 May 20. doi: 10.1055/a-2604-5823.
    PubMed    


  5. BAEHR M, Dietrich I, Liepe K
    [99mTc]Tc-PSMA SPECT/CT is a promising tool in the staging of renal cell carcinoma.
    Nuklearmedizin. 2025 May 12. doi: 10.1055/a-2578-7222.
    PubMed    


    April 2025
  6. BUCHERT R, Drzezga A, Schreckenberger M, Langen KJ, et al
    The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023.
    Nuklearmedizin. 2025 Apr 15. doi: 10.1055/a-2566-1487.
    PubMed     Abstract available


  7. LUNA R, Laheru DA, Shin EJ, Lossos C, et al
    Pancreatic Neuroendocrine Tumor incidentally found on 68Ga-PSMA PET/CT.
    Nuklearmedizin. 2025;64:177-179.
    PubMed    


  8. WENDLER T, Rogasch JMM, Bastian MB, Burchert W, et al
    Digitalization of Nuclear Medicine in Germany - Status Quo 2024.
    Nuklearmedizin. 2025;64:156-162.
    PubMed     Abstract available


  9. ORBOM A, Evans-Axelsson S, Jansson B, Vilhelmsson Timmermand O, et al
    Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model.
    Nuklearmedizin. 2025;64:163-169.
    PubMed     Abstract available


  10. EBRAHIMIFARD A, Rajabi H, Geramifar P, Luster M, et al
    The impact of the xSPECT reconstruction algorithms on the recovery coefficients value for small tumors: a phantom study with 177Lu.
    Nuklearmedizin. 2025;64:132-140.
    PubMed     Abstract available


  11. VOGT JK, Vogt WK, Heinzel A, Mottaghy FM, et al
    Comparison of 2D and 3D lung lobe quantification with Ventilation/Perfusion Ratio.
    Nuklearmedizin. 2025;64:142-149.
    PubMed     Abstract available


    March 2025
  12. BAUDE JK, Mottaghy FM, Derlin T, Fischer A, et al
    PSMA - Targeted Clinical Molecular Imaging of Atherosclerosis: Correlation with Cardiovascular Risk Factors.
    Nuklearmedizin. 2025;64:13-21.
    PubMed     Abstract available


    January 2025
  13. VURAL TOPUZ O, Bagbudar S, Aksu A, Soylemez Akkurt T, et al
    Radiomic signatures derived from baseline 18F FDG PET/CT imaging can predict tumor-infiltrating lymphocyte values in patients with primary breast cancer.
    Nuklearmedizin. 2025 Jan 28. doi: 10.1055/a-2512-8212.
    PubMed     Abstract available


    December 2024
  14. CEGLA P, Currie G, Wroblewska JP, Kazmierska J, et al
    [18F]FDG PET/CT Imaging and Hematological Parameters Can Help Predict HPV Status in Head and Neck Cancer.
    Nuklearmedizin. 2024 Dec 4. doi: 10.1055/a-2365-7808.
    PubMed     Abstract available


  15. GRUNERT M, Schenke SA, Konrad A, Schutze C, et al
    Thyroid scintigraphy: establishing a clinically useful normal range for 99mTc pertechnetate uptake.
    Nuklearmedizin. 2024;63:337-346.
    PubMed     Abstract available


    November 2024
  16. RUGGIERO C, Maracaja D, Rowe SP
    Langerhans Cell Histiocytosis-Associated Vertebra Plana on FDG PET.
    Nuklearmedizin. 2024 Nov 27. doi: 10.1055/a-2438-7469.
    PubMed    


  17. ZHAO G, Huang Z
    A Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor on 18F-FDG PET/CT.
    Nuklearmedizin. 2024 Nov 20. doi: 10.1055/a-2383-2527.
    PubMed     Abstract available


  18. SCHULZ L, Funk GC, Kirchbacher K, Egger E, et al
    Comparison of whole-body 18F-FDG-PET/CT with 18F-FDG-PET/CT limited to skull base to upper abdomen for primary staging of lung cancer - a retrospective explorative analysis.
    Nuklearmedizin. 2024 Nov 11. doi: 10.1055/a-2438-7278.
    PubMed     Abstract available


    October 2024
  19. VOLTIN CA, Spreckelmeyer S, Essler M, Holzgreve A, et al
    Toward the future of nuclear medicine: How young professionals are getting involved and what plans they have.
    Nuklearmedizin. 2024;63:284-286.
    PubMed    


  20. VOGEL J, Haghghi S, Herkula C, Petersen M, et al
    Interobserver Agreement of visual and semi-quantitative methods in 99mTc-Methoxy-Isobuty-Isonitrile (MIBI) imaging for risk stratification of hypofunctional thyroid nodules.
    Nuklearmedizin. 2024;63:294-299.
    PubMed     Abstract available


  21. ZEIDLER R, Tiepolt S, Hesse S, Sabri O, et al
    Superimposing kidneys in [99mTc]MAG-3 and [99mTc]DMSA-scintigraphy in a tricky case of an extensive, displacing growing retroperitoneal liposarcoma.
    Nuklearmedizin. 2024;63:306-307.
    PubMed    


    September 2024
  22. JAFARI E, Manafi-Farid R, Ahmadzadehfar H, Salek F, et al
    Prognostic Significance of Baseline Clinical and [68Ga]Ga-PSMA PET Derived Parameters on Biochemical Response, Overall Survival, and PSA Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing [177Lu]Lu
    Nuklearmedizin. 2024 Sep 3. doi: 10.1055/a-2365-8113.
    PubMed     Abstract available


    August 2024
  23. RAHBAR NIKOUKAR L, Seifert R, Ventura D, Schindler P, et al
    Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands.
    Nuklearmedizin. 2024 Aug 29. doi: 10.1055/a-2383-2468.
    PubMed     Abstract available


  24. VOGT JK, Vogt WK, Heinzel A, Mottaghy FM, et al
    Computational Decision Support for PE Diagnosis based on Ventilation Perfusion Ratio.
    Nuklearmedizin. 2024;63:259-266.
    PubMed     Abstract available


    July 2024
  25. LANDAU F, Hermann S, Schelhaas S, Schafers M, et al
    18F-labelled gentiobiose as potential PET-radiotracer for specific bacterial imaging: precursor synthesis, radiolabelling and in vitro evaluation.
    Nuklearmedizin. 2024 Jul 31. doi: 10.1055/a-2365-8054.
    PubMed     Abstract available


  26. BREDENSTEINER L, Ventura D, Rassek P, Schafers M, et al
    Determination of the optimal imaging protocol for [18F]PSMA-PET-CT for the detection of bone metastases in prostate cancer patients.
    Nuklearmedizin. 2024 Jul 12. doi: 10.1055/a-2344-6825.
    PubMed     Abstract available


    May 2024
  27. SCHMIDT M, Hohberg M, Felcht M, Kuhn T, et al
    [Nuclear medicine procedure guideline for sentinel lymph node localization].
    Nuklearmedizin. 2024 May 24. doi: 10.1055/a-2319-8306.
    PubMed     Abstract available


  28. HEIDEMANNS S, Trautmann S, Weidt D, Hellwig D, et al
    Update of the competence-based catalog of learning objectives in nuclear medicine for the study of human medicine in Germany.
    Nuklearmedizin. 2024 May 22. doi: 10.1055/a-2319-7549.
    PubMed     Abstract available


    April 2024
  29. WIELENBERG CF, Fostitsch JC, Volz C, Marks R, et al
    FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL).
    Nuklearmedizin. 2024 Apr 9. doi: 10.1055/a-2283-8417.
    PubMed     Abstract available


  30. BOCK F, Frerker B, Schubert L, Rennau H, et al
    Impact of 68Ga-PSMA PET/CT on radiation treatment planning of prostate cancer patients.
    Nuklearmedizin. 2024 Apr 5. doi: 10.1055/a-2284-0593.
    PubMed     Abstract available


  31. SAEED S, Dimopoulos I, Begum N, Kroger JR, et al
    [Not Available].
    Nuklearmedizin. 2024;63:78-80.
    PubMed    


  32. WERNER R, Haug A, Buske C, Heidegger S, et al
    CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
    Nuklearmedizin. 2024;63:57-61.
    PubMed     Abstract available


    March 2024
  33. GACULA SIG, Kunte SC, Unterrainer LM, Rubenthaler J, et al
    Correction: Divergent growth on [18F]FDG PET/CT in a case of co-existing pulmonary metastatic leiomyosarcoma and papillary thyroid carcinoma.
    Nuklearmedizin. 2024 Mar 25. doi: 10.1055/a-2286-9571.
    PubMed    


  34. USLU H, Sahin D, Tatoglu MT, Ibisoglu E, et al
    Growing Teratoma Syndrome Revealed By F-18 FDG PET/CT.
    Nuklearmedizin. 2024 Mar 14. doi: 10.1055/a-2273-2350.
    PubMed    


  35. GACULA SIG, Kunte SC, Unterrainer LM, Rubenthaler J, et al
    Divergent growth on [18F]FDG PET/CT in a case of co-existing pulmonary metastatic leiomyosarcoma and papillary thyroid carcinoma.
    Nuklearmedizin. 2024 Mar 11. doi: 10.1055/a-2273-2447.
    PubMed    


  36. LIU Y, Tang W, Huang Z
    Correction: 99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Primary Hepatic Osteosarcoma.
    Nuklearmedizin. 2024 Mar 4. doi: 10.1055/a-2275-1035.
    PubMed    


    February 2024
  37. CHEN M, Liu Y
    Correction: 18F-FDG PET/CT images of adult pulmonary blastoma: a case report.
    Nuklearmedizin. 2024 Feb 20. doi: 10.1055/a-2265-4049.
    PubMed    


  38. AYDAR S, Knobl H, Burchert W, Lindner O, et al
    Diagnostic accuracy of artificial intelligence-enabled vectorcardiography versus myocardial perfusion SPECT in patients with suspected or known coronary heart disease.
    Nuklearmedizin. 2024 Feb 20. doi: 10.1055/a-2263-2322.
    PubMed     Abstract available


  39. CHEN M, Liu Y
    18F-FDG PET/CT images of adult pulmonary blastoma: a case report.
    Nuklearmedizin. 2024 Feb 7. doi: 10.1055/a-2237-8775.
    PubMed    


  40. UMUTLU L, Nensa F, Demircioglu A, Antoch G, et al
    Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer.
    Nuklearmedizin. 2024;63:34-42.
    PubMed     Abstract available


  41. FISCHER M, Schneider-Eicke J
    Nonosseous bone seeking tracer focal uptake in the conventional scintigraphy.
    Nuklearmedizin. 2024;63:45-47.
    PubMed    


  42. DIETLEIN M, Grunwald F, Schmidt M, Kreissl MC, et al
    [Guideline for Radioiodine Therapy for Benign Thyroid Diseases (6/2022 - AWMF No. 031-003)].
    Nuklearmedizin. 2024;63:8-20.
    PubMed     Abstract available


    January 2024
  43. FREUDENBERG R, Kastner D, Kotzerke J, Brogsitter C, et al
    [Evaluation of risk analysis in treatment with unsealed radioactive substances in nuclear medicine].
    Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2237-8639.
    PubMed    


  44. MAMAN A
    Incidental Papillary Thyroid Carcinoma Detected by Ga-68 DOTATATE PET/CT: A Rare Case Study and Clinical Considerations.
    Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2238-4186.
    PubMed    


  45. NOURBAKHSH S, Salehi Y, Farzanehfar S, Ghaletaki R, et al
    FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2185-7746.
    PubMed     Abstract available


  46. ARSLANTAS E, Aycicek A, Esen Akkas B, Tahtakesen Gucer TN, et al
    The Role of FDG- PET/CT in Detecting Bone Marrow Involvement in Childhood Solid Tumors.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9441.
    PubMed     Abstract available


  47. VURAL TOPUZ O, Bagbudar S
    Cervical Cancer Metastasis to the Stomach Masquerading as Primary Gastric Cancer: A Case Report of a Rare Metastasis Detected via 18F-FDG PET/CT.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9673.
    PubMed    


  48. SANTO G, Di Santo G, Zelger B, Virgolini I, et al
    Incidental Finding of a Pancreatic Adenocarcinoma on [68Ga]Ga-PSMA-11 PET/CT in a mCRPC patient under [177Lu]Lu-PSMA-617 Radioligand Therapy.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2221-3220.
    PubMed    


    December 2023
  49. SERFLING SE, Buck A, Rowe SP, Higuchi T, et al
    Red Bull PET/CT.
    Nuklearmedizin. 2023 Dec 22. doi: 10.1055/a-2195-0138.
    PubMed     Abstract available


  50. ROGASCH JMM, Shi K, Kersting D, Seifert R, et al
    Methodological evaluation of original articles on radiomics and machine learning for outcome prediction based on positron emission tomography (PET).
    Nuklearmedizin. 2023;62:361-369.
    PubMed     Abstract available


  51. WENDLER T, Kreissl MC, Schemmer B, Rogasch JMM, et al
    Artificial Intelligence-powered automatic volume calculation in medical images - available tools, performance and challenges for nuclear medicine.
    Nuklearmedizin. 2023;62:343-353.
    PubMed     Abstract available


  52. HELLWIG D, Hellwig NC, Boehner S, Fuchs T, et al
    Artificial Intelligence and Deep Learning for Advancing PET Image Reconstruction: State-of-the-Art and Future Directions.
    Nuklearmedizin. 2023;62:334-342.
    PubMed     Abstract available


  53. MIEDERER I, Rogasch JMM, Wendler T
    AI in Nuclear Medicine - a review of the current situation.
    Nuklearmedizin. 2023;62:332-333.
    PubMed    


    November 2023
  54. LOHMANN P, Bundschuh RA, Miederer I, Mottaghy FM, et al
    Clinical Applications of Radiomics in Nuclear Medicine.
    Nuklearmedizin. 2023 Nov 7. doi: 10.1055/a-2191-3271.
    PubMed     Abstract available


    October 2023
  55. FUCHS T, Kaiser L, Muller D, Papp L, et al
    Enhancing Interoperability and Harmonisation of Nuclear Medicine Image Data and Associated Clinical Data.
    Nuklearmedizin. 2023 Oct 31. doi: 10.1055/a-2187-5701.
    PubMed     Abstract available


  56. RASSEK P, Bobe S, Kies P, Roll W, et al
    The value of core needle biopsy in the diagnostic workup of a [18F]FDG-PET positive thyroid metastasis from colorectal cancer.
    Nuklearmedizin. 2023 Oct 23. doi: 10.1055/a-2178-6908.
    PubMed    


  57. BROSCH-LENZ JF, Delker A, Schmidt F, Tran-Gia J, et al
    On the Use of Artificial Intelligence for Dosimetry of Radiopharmaceutical Therapies.
    Nuklearmedizin. 2023 Oct 12. doi: 10.1055/a-2179-6872.
    PubMed     Abstract available


  58. MOON H, Ku EJ, Kim C
    Ectopic Thyroid Tissue in the Uterus Identified by Iodine-131 SPECT/CT.
    Nuklearmedizin. 2023;62:294-295.
    PubMed    


  59. KUSTNER T, Hepp T, Seith F
    Multiparametric Oncologic Hybrid Imaging: Machine Learning Challenges and Opportunities.
    Nuklearmedizin. 2023;62:306-313.
    PubMed     Abstract available


    September 2023
  60. DEININGER K, Raacke JN, Yousefzadeh-Nowshahr E, Kropf-Sanchen C, et al
    Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify prognostic groups in low-risk NSCLC.
    Nuklearmedizin. 2023 Sep 11. doi: 10.1055/a-2150-4130.
    PubMed     Abstract available


  61. MIEDERER I, Rogasch JMM, Fischer R, Fuchs T, et al
    The Medical Informatics Initiative and the Network University Medicine - Perspectives for Nuclear Medicine.
    Nuklearmedizin. 2023 Sep 8. doi: 10.1055/a-2067-7642.
    PubMed     Abstract available


    August 2023
  62. FROHLICH M, Schmalzing M, Buck A, Bley TA, et al
    PET-Derived Increased Inflammation in Large Vessels is linked to Relapse-Free Survival in Patients with Giant Cell Arteritis.
    Nuklearmedizin. 2023;62:229-234.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.